|
Cytotherapy provides a platform to disseminate CGT translation research globally and we invite you to submit your manuscript when ready for publication.
We are currently recruiting manuscripts in gene therapy, immunotherapy, EV and MSC research, regulatory frameworks and policy issues, and advances in CGT product manufacturing, commercialization, and patient access.
- Donald G. Phinney, PhD, Cytotherapy Senior Editor
|